Insider Selling: Bath & Body Works, Inc. (NYSE:BBWI) Insider Sells 4,285 Shares of Stock

Bath & Body Works, Inc. (NYSE:BBWI) insider Thomas E. Mazurek sold 4,285 shares of the business’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the transaction, the insider now directly owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Bath & Body Works Price Performance

BBWI stock traded up $0.57 during trading on Thursday, reaching $50.02. 2,257,412 shares of the stock traded hands, compared to its average volume of 2,789,631. The business’s 50 day moving average price is $45.05 and its 200-day moving average price is $38.74. Bath & Body Works, Inc. has a 52-week low of $27.30 and a 52-week high of $50.17. The firm has a market capitalization of $11.25 billion, a PE ratio of 12.84, a P/E/G ratio of 1.60 and a beta of 1.85.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.21. The firm had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.84 billion. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The firm’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.86 earnings per share. On average, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date of this dividend was Thursday, February 22nd. Bath & Body Works’s dividend payout ratio is presently 20.78%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Shell Asset Management Co. lifted its stake in shares of Bath & Body Works by 180.0% during the third quarter. Shell Asset Management Co. now owns 56,344 shares of the company’s stock worth $1,904,000 after purchasing an additional 36,222 shares in the last quarter. Pearl River Capital LLC lifted its stake in shares of Bath & Body Works by 145.6% during the third quarter. Pearl River Capital LLC now owns 31,364 shares of the company’s stock worth $1,060,000 after purchasing an additional 18,596 shares in the last quarter. Aigen Investment Management LP acquired a new position in shares of Bath & Body Works during the third quarter worth about $1,697,000. Itau Unibanco Holding S.A. acquired a new position in shares of Bath & Body Works in the second quarter worth about $356,000. Finally, Vanguard Group Inc. lifted its stake in shares of Bath & Body Works by 0.3% in the third quarter. Vanguard Group Inc. now owns 25,689,543 shares of the company’s stock worth $868,307,000 after acquiring an additional 67,920 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on BBWI shares. The Goldman Sachs Group boosted their price target on Bath & Body Works from $49.00 to $56.00 and gave the stock a “buy” rating in a report on Monday, March 4th. TD Cowen boosted their price target on Bath & Body Works from $35.00 to $55.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. UBS Group boosted their price target on Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a report on Monday, March 4th. Robert W. Baird lifted their price objective on Bath & Body Works from $50.00 to $54.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Finally, Barclays downgraded Bath & Body Works from an “overweight” rating to an “equal weight” rating and lifted their price objective for the company from $37.00 to $45.00 in a research report on Thursday, January 4th. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $45.80.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.